Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark - The Lancet Regional Health – Europe
JCDD | Free Full-Text | Dual Antiplatelet Therapy with Parenteral P2Y12 Inhibitors: Rationale, Evidence, and Future Directions
Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan | Scientific Reports
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial - The Lancet
How to Switch from Clopidogrel to Prasugrel or Ticagrelor - ppt download
Editor's Corner | DAPT, Our Genome and Clopidogrel "Resistance": Are We Near an Answer to "Which Drug, When?" - American College of Cardiology
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Journal of Invasive Cardiology - An acute antiplatelet-switching strategy: Using prasugrel or ticagrelor for rapid and reliable periprocedural antiplatelet action, followed by a switch to clopidogrel -- The SWITCH Study Antoine E.
Switching between P2Y12 inhibitors: Rationale, methods, and expected consequences - ScienceDirect
International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies | Circulation
![PDF] De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9821495c3b180b474079b1b8e98cc52218703a27/4-Figure1-1.png "PDF] De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early? | Semantic Scholar")
PDF] De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early? | Semantic Scholar
Algorithm for switching between oral P2Y12 inhibitors in the acute and... | Download Scientific Diagram
Should You Switch the DAPT Agent a Month After ACS? | Clinician Reviews
Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study | Stroke: Vascular and Interventional Neurology
Switching mode between the P2Y 12 platelet receptor inhibitors, acute... | Download Scientific Diagram
Switching P2Y12-receptor inhibitors in patients with coronary artery disease | Nature Reviews Cardiology
When to Switch and How to Switch - ppt download
Frontiers | Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
mandeep singh on X: "Switching P2Y12 after PCI: 1. Wait 24h except Clopidogrel (C) to ticagrelor (T)/Prasugrel (P). 2. Give loading dose <30d and maintenance dose after except T to P/C switch:
Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 | tctmd.com
How to Switch from Clopidogrel to Prasugrel or Ticagrelor - ppt download
Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram
Recomendaciones del manejo antiagregante en Cardiología. Documento de revisión de la Sociedad Andaluza de Cardiología | Cardiocore
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
SOLACI | Latin American Society of Interventional Cardiology
